The early activation of toll-like receptor (TLR)-3 initiates kidney injury after ischemia and reperfusion

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Paulus, Patrick ^a   Rupprecht, Katrin ^a   Baer, Patrick ^a   Obermüller, Nicholas ^a   Penzkofer, Daniela ^b   Reissig, Christin ^a   Scheller, Bertram ^a   Holfeld, Johannes ^c   Zacharowski, Kai ^a   Dimmeler, Stefanie ^b   Schlammes, Joelle ^a   Urbschat, Anja ^d  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TOLL LIKE RECEPTOR 3; TLR3 PROTEIN, MOUSE;

ACUTE KIDNEY FAILURE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY CLAMP; ARTICLE; CELL INVASION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE ACTIVATION; INFLAMMATION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY TUBULE NECROSIS; MALE; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; RENAL ARTERY; REPERFUSION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; KIDNEY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; REPERFUSION INJURY;

ANIMALS; KIDNEY; KIDNEY TUBULES; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 84899747091     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094366     Document Type: Article

References (45)

1. Ympa YP, Sakr Y, Reinhart K, Vincent JL (2005) Has mortality from acute renal failure decreased? A systematic review of the literature. The American journal of medicine 118: 827-832. (Pubitemid 41097456)
2. Urbschat A, Obermuller N, Haferkamp A (2011) Biomarkers of kidney injury. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals 16 Suppl 1: S22-30.
3. Bonventre JV, Zuk A (2004) Ischemic acute renal failure: an inflammatory disease? Kidney international 66: 480-485. (Pubitemid 38981982)
4. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, et al. (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA: the journal of the American Medical Association 294: 813-818. (Pubitemid 41175724)
5. Lote CJ, Harper L, Savage CO (1996) Mechanisms of acute renal failure. British journal of anaesthesia 77: 82-89. (Pubitemid 26229915)
6. Schrier RW, Wang W (2004) Acute renal failure and sepsis. The New England journal of medicine 351: 159-169.
7. Schrier RW, Wang W, Poole B, Mitra A (2004) Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. The Journal of clinical investigation 114: 5-14. (Pubitemid 39071636)
8. Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. The New England journal of medicine 334: 1448-1460. (Pubitemid 126590563)
9. Shirali AC, Goldstein DR (2008) Tracking the toll of kidney disease. Journal of the American Society of Nephrology: JASN 19: 1444-1450.
10. Anders HJ (2010) Toll-like receptors and danger signaling in kidney injury. Journal of the American Society of Nephrology: JASN 21: 1270-1274.
11. Anders HJ, Banas B, Schlondorff D (2004) Signaling danger: toll-like receptors and their potential roles in kidney disease. Journal of the American Society of Nephrology: JASN 15: 854-867. (Pubitemid 38375304)
12. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, et al. (2010) The role of Toll-like receptors in renal diseases. Nature reviews Nephrology 6: 224-235.
13. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. The Journal of clinical investigation 115: 2894-2903. (Pubitemid 41434417)
14. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, et al. (2007) TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and-independent pathways. Journal of immunology 178: 6252-6258. (Pubitemid 46717408)
15. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, et al. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. The Journal of clinical investigation 117: 2847-2859. (Pubitemid 47529615)
16. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738. (Pubitemid 33009951)
17. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, et al. (2002) Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1-and TLR2-deficient mice. Nature medicine 8: 878-884.
18. Zarember KA, Godowski PJ (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. Journal of immunology 168: 554-561. (Pubitemid 34049553)
19. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, et al. (2002) Roles of tolllike receptors in C-C chemokine production by renal tubular epithelial cells. Journal of immunology 169: 2026-2033. (Pubitemid 34857667)
20. Nishimura M, Naito S (2005) Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biological & pharmaceutical bulletin 28: 886-892. (Pubitemid 40740661)
21. Urbschat A, Zacharowski K, Obermuller N, Rupprecht K, Penzkofer D, et al. (2014) The small fibrinopeptide bbeta15-42 as renoprotective agent preserving the endothelial and vascular integrity in early ischemia reperfusion injury in the mouse kidney. PloS one 9: e84432.
22. Paulus P, Ockelmann P, Tacke S, Karnowski N, Ellinghaus P, et al. (2012) Deguelin attenuates reperfusion injury and improves outcome after orthotopic lung transplantation in the rat. PLoS One 7: e39265.
23. Paulus P, Holfeld J, Urbschat A, Mutlak H, Ockelmann PA, et al. (2013) Prednisolone as preservation additive prevents from ischemia reperfusion injury in a rat model of orthotopic lung transplantation. PLoS One 8: e73298.
24. Paulus P, Stanley ER, Schafer R, Abraham D, Aharinejad S (2006) Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer research 66: 4349-4356.
25. Bellomo R, Kellum JA, Ronco C (2012) Acute kidney injury. Lancet 380: 756-766.
26. Nguyen MT, Devarajan P (2008) Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol 23: 2151-2157.
27. Obermuller N, Geiger H, Weipert C, Urbschat A (2013) Current developments in early diagnosis of acute kidney injury. International urology and nephrology.
28. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, et al. (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534-2543. (Pubitemid 37169339)
29. Mori K, Nakao K (2007) Neutrophil gelatinase-associated lipocalin as the realtime indicator of active kidney damage. Kidney Int 71: 967-970. (Pubitemid 46741985)
30. Schafer R, Abraham D, Paulus P, Blumer R, Grimm M, et al. (2003) Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy. Circulation 108: 1585-1591. (Pubitemid 37187785)
31. Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. The New England journal of medicine 364: 656-665.
32. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion-from mechanism to translation. Nature medicine 17: 1391-1401.
33. Kuhlicke J, Frick JS, Morote-Garcia JC, Rosenberger P, Eltzschig HK (2007) Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PloS one 2: e1364.
34. Chen J, John R, Richardson JA, Shelton JM, Zhou XJ, et al. (2011) Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney international 79: 288-299.
35. McKay DB (2011) Intracellular pattern recognition receptors and renal ischemia. Critical reviews in immunology 31: 297-306.
36. Doyle S, Vaidya S, O'Connell R, Dadgostar H, Dempsey P, et al. (2002) IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17: 251-263. (Pubitemid 35279547)
37. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13: 816-825.
38. Vanhoutte F, Paget C, Breuilh L, Fontaine J, Vendeville C, et al. (2008) Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells. Immunology letters 116: 86-94.
39. Gonzalez-Villalobos RA, Shen XZ, Bernstein EA, Janjulia T, Taylor B, et al. (2013) Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme. Journal of molecular medicine.
40. Toda N, Nakanishi S, Tanabe S (2013) Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications. British journal of pharmacology 168: 519-533.
41. Hause L, Al-Salleeh FM, Petro TM (2007) Expression of IL-27 p28 by Theiler's virus-infected macrophages depends on TLR3 and TLR7 activation of JNK-MAP-kinases. Antiviral research 76: 159-167. (Pubitemid 47410320)
42. Hou L, Sasaki H, Stashenko P (2000) Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection. Infection and immunity 68: 4681-4687. (Pubitemid 30497741)
43. Kusagaya H, Fujisawa T, Yamanaka K, Mori K, Hashimoto D, et al. (2013) TLR-Mediated Airway IL-17C Enhances Epithelial Host Defense in an Autocrine/Paracrine Manner. American journal of respiratory cell and molecular biology.
44. Sabbatucci M, Purificato C, Fantuzzi L, Gessani S (2011) Toll-like receptor cross-talk in human monocytes regulates CC-chemokine production, antigen uptake and immune cell recruitment. Immunobiology 216: 1135-1142.
45. Yang X, Murthy V, Schultz K, Tatro JB, Fitzgerald KA, et al. (2006) Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells. American journal of physiology Heart and circulatory physiology 291: H2334-2343.